Bicycle Therapeutics plc: CEO Lee Kevin sold 7,805 shares

What happened

• Lee Kevin, chief executive officer, sold a total of 7,805 shares: 6,167 shares on Oct 2, 2026 at a weighted average price of $3.47 for $21,399, and 1,638 shares on Oct 5, 2026 at a weighted average price of $3.57 for $5,848. The filing reports total proceeds of $27,247.

Key details

• Transaction dates and prices: Oct 2, 2026 — 6,167 shares at $3.47 (weighted average; see footnote); Oct 5, 2026 — 1,638 shares at $3.57 (weighted average; see footnote).
• Shares owned after the transaction: not reported in this filing.
• Relevant footnotes:
  • F1: Sale on Oct 2 was to satisfy statutory tax withholding obligations in connection with RSU vesting (a "sell to cover" required by the award agreement).
  • F2: Oct 2 price is a weighted average; shares were sold in multiple transactions at prices ranging from $3.41 to $3.525. Detailed breakdown available on request.
  • F3: Oct 5 price is a weighted average; shares were sold in multiple transactions at prices ranging from $3.56 to $3.57. Detailed breakdown available on request.
• Filing date: Oct 6, 2026. The filing does not indicate it was late.

Why it may matter

• Per the filing, the Oct 2 sale was a sell-to-cover to satisfy tax withholding for vested RSUs rather than a discretionary sale by the reporting person.
• Both reported prices are weighted averages covering multiple transactions (see footnotes for ranges).
• A filing does not show why the insider traded or why the company acted.